Market Exclusive

AbbVie Inc (NYSE:ABBV) gets upgraded to Buy by UBS Group with a price target of $79.00

Analyst Ratings For AbbVie Inc (NYSE:ABBV)

Today, AbbVie Inc (NYSE:ABBV) stock received an upgrade by UBS Group from Neutral to Buy with a price target of $79.00.

There are 7 Hold Ratings, 6 Buy Ratings, 2 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AbbVie Inc (NYSE:ABBV) is Hold with a consensus target price of $90.4675 per share, a potential 27.63% upside.

Some recent analyst ratings include

Recent Trading Activity for AbbVie Inc (NYSE:ABBV)
Shares of AbbVie Inc closed the previous trading session at 70.86 up +1.37 1.99% with shares trading hands.

Exit mobile version